Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19.
Gori M, Ghirardi A, D'Elia E, Imeri G, Di Marco F, Gavazzi A, Carobbio A, Balestrieri G, Giammarresi A, Trevisan R, Amoroso M, Raimondi F, Novelli L, Magro B, Mangia G, Lorini FL, Fagiuoli S, Barbui T, Rizzi M, Cosentini R, Sironi S, Senni M; of HPG23 Covid-19 Study Group. Gori M, et al. Among authors: trevisan r. Eur J Prev Cardiol. 2022 May 5;29(5):e196-e199. doi: 10.1093/eurjpc/zwab143. Eur J Prev Cardiol. 2022. PMID: 34535993 No abstract available.
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study.
Gori M, Canova P, Calabrese A, Cioffi G, Trevisan R, De Maria R, Grosu A, Iacovoni A, Fontana A, Ferrari P, Greene SJ, Gheorghiade M, Parati G, Gavazzi A, Senni M. Gori M, et al. Among authors: trevisan r. Int J Cardiol. 2017 Dec 1;248:414-420. doi: 10.1016/j.ijcard.2017.06.101. Epub 2017 Jun 28. Int J Cardiol. 2017. PMID: 28709699
[Grey zones on diabetes in cardiovascular disease. Expert opinion].
Trevisan R, Grosu A, Avogaro A, Agostoni P, Ceconi C, Genovese S, Bossi A, Pitì A, Senni M, Maggioni AP. Trevisan R, et al. G Ital Cardiol (Rome). 2020 Dec;21(12):916-922. doi: 10.1714/3472.34545. G Ital Cardiol (Rome). 2020. PMID: 33231210 Italian.
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients.
Gori M, Berzuini C, D'Elia E, Ghirardi A, Bernardinelli L, Gavazzi A, Balestrieri G, Giammarresi A, Trevisan R, Di Marco F, Bellasi A, Amoroso M, Raimondi F, Novelli L, Magro B, Mangia G, Lorini FL, Guagliumi G, Fagiuoli S, Parati G, Senni M. Gori M, et al. Among authors: trevisan r. J Hypertens. 2022 Apr 1;40(4):666-674. doi: 10.1097/HJH.0000000000003059. J Hypertens. 2022. PMID: 34889863 Free PMC article.
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study.
Solerte SB, D'Addio F, Trevisan R, Lovati E, Rossi A, Pastore I, Dell'Acqua M, Ippolito E, Scaranna C, Bellante R, Galliani S, Dodesini AR, Lepore G, Geni F, Fiorina RM, Catena E, Corsico A, Colombo R, Mirani M, De Riva C, Oleandri SE, Abdi R, Bonventre JV, Rusconi S, Folli F, Di Sabatino A, Zuccotti G, Galli M, Fiorina P. Solerte SB, et al. Among authors: trevisan r. Diabetes Care. 2020 Dec;43(12):2999-3006. doi: 10.2337/dc20-1521. Epub 2020 Sep 29. Diabetes Care. 2020. PMID: 32994187 Free PMC article.
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study.
Ruggenenti P, Cortinovis M, Parvanova A, Trillini M, Iliev IP, Bossi AC, Belviso A, Aparicio MC, Trevisan R, Rota S, Perna A, Peracchi T, Rubis N, Martinetti D, Prandini S, Gaspari F, Carrara F, De Cosmo S, Tonolo G, Mangili R, Remuzzi G; VARIETY Study Organization. Ruggenenti P, et al. Among authors: trevisan r. PLoS Med. 2021 Jul 14;18(7):e1003691. doi: 10.1371/journal.pmed.1003691. eCollection 2021 Jul. PLoS Med. 2021. PMID: 34260595 Free PMC article. Clinical Trial.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Bakris GL, et al. JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081. JAMA. 2015. PMID: 26325557 Clinical Trial.
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P; BENEDICT Study Group. De Cosmo S, et al. Among authors: trevisan r. Diabetes. 2009 Dec;58(12):2920-9. doi: 10.2337/db09-0407. Epub 2009 Aug 31. Diabetes. 2009. PMID: 19720797 Free PMC article. Clinical Trial.
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.
Rurali E, Noris M, Chianca A, Donadelli R, Banterla F, Galbusera M, Gherardi G, Gastoldi S, Parvanova A, Iliev I, Bossi A, Haefliger C, Trevisan R, Remuzzi G, Ruggenenti P; BENEDICT Study Group. Rurali E, et al. Among authors: trevisan r. Diabetes. 2013 Oct;62(10):3599-609. doi: 10.2337/db13-0530. Epub 2013 Jun 3. Diabetes. 2013. PMID: 23733198 Free PMC article.
340 results